Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073736
Status:
COMPLETED
Last Update Posted:
2011-08-12
First Post:
2003-12-03
Brief Title:
Safety and Tolerability of IV Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma
Sponsor:
Ligand Pharmaceuticals
Organization:
Ligand Pharmaceuticals
Organization Data
Organization:
Ligand Pharmaceuticals
Class:
INDUSTRY
Study ID:
HCC-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ligand Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Project Management
Old Organization:
Ligand Pharmaceuticals